Acetonitrile → 5-(1',2',3',4',5',6'-hexahydro-[2,4']bipyridinyl-6-yl)-2-phenoxymethyl-6,7-dihydro-5H-pyrazolo[1,5-a]pyrazin-4-one
반응식
FC(F)(F)C(O)=[O:4].C(OC([N:15]1[CH2:20][CH2:19][CH:18]([C:21]2[CH:26]=[CH:25][CH:24]=[C:23]([N:27]3[CH2:32][CH2:31][N:30]4[N:33]=[C:34]([CH2:36][O:37][C:38]5[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=5)[CH:35]=[C:29]4[C:28]3=[O:44])[N:22]=2)[CH2:17][CH2:16]1)=O)(C)(C)C.C([O-])([O-])=O.[Na+].[Na+].C(#N)C>C(Cl)Cl.O>[NH4+:15].[OH-:4].[N:22]1[C:23]([N:27]2[CH2:32][CH2:31][N:30]3[N:33]=[C:34]([CH2:36][O:37][C:38]4[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=4)[CH:35]=[C:29]3[C:28]2=[O:44])=[CH:24][CH:25]=[CH:26][C:21]=1[CH:18]1[CH2:19][CH2:20][NH:15][CH2:16][CH2:17]1참가 물질
반응물 4
생성물 2
시약·촉매·용매 2
실험 절차
Trifluoroacetic acid (0.5 mL) was added to a stirred solution of 6-(4-oxo-2-phenoxymethyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-3′,4′,5′,6′-tetrahydro-2′H-[2,4′]bipyridinyl-1′-carboxylic acid tert-butyl ester (44 mg, 0.087 mmol) in DCM (0.5 mL). The mixture was stirred at room temperature for 16 hours. The mixture was basified with a saturated solution of Na2CO3 and extracted with more DCM. The organic layer was separated, dried (MgSO4), filtered and the solvents evaporated in vacuo. The crude product was purified by flash column chromatography (silica; 7 N solution of ammonia in MeOH in DCM 0/100 to 10/90). The desired fractions were collected and the solvents evaporated in vacuo. The product was repurified by ion exchange chromatography using an ISOLUTE SCX2 cartridge and eluting with MeOH and 7 N solution of ammonia in MeOH. The desired fractions were collected and the solvents evaporated in vacuo. The product was triturated with DIPE and repurified by RP HPLC on (C18 XBridge 30×100 5 um). Mobile phase (Gradient from 80% 0.1% NH4CO3H/NH4OH pH 9 solution in H2O, 20% ACN to 0% 0.1% NH4CO3H/NH4OH pH 9 solution in H2O, 100% ACN) to yield 5-(1′,2′,3′,4′,5′,6′-hexahydro-[2,4′]bipyridinyl-6-yl)-2-phenoxymethyl-6,7-dihydro-5H-pyrazolo[1,5-a]pyrazin-4-one (8 mg, 24% yield) as a white solid. 1H NMR (400 MHz, CDCl3d) δ ppm 1.66 (br. s., 1H), 1.70-1.83 (m, 2H), 1.89 (dd, J=12.0, 1.8 Hz, 2H), 2.76 (td, J=12.3, 2.8 Hz, 2H), 2.74-2.83 (m, 1H), 3.21 (dt, J=12.0, 2.8 Hz, 2H), 4.46-4.54 (m, 2H), 4.58-4.68 (m, 2H), 5.13 (s, 2H), 6.93-7.00 (m, 2H), 7.00-7.05 (m, 2H), 7.06 (s, 1H), 7.27-7.34 (m, 2H), 7.66 (t, J=8.0 Hz, 1H), 7.87 (d, J=8.1 Hz, 1H).
후처리
- extractionextracted with more DCM
- customThe organic layer was separated
- dry with materialdried (MgSO4)
- filtrationfiltered
- customthe solvents evaporated in vacuo
- customThe crude product was purified by flash column chromatography (silica; 7 N solution of ammonia in MeOH in DCM 0/100 to 10/90)
- customThe desired fractions were collected
- customthe solvents evaporated in vacuo
- customThe product was repurified by ion exchange chromatography
- washeluting with MeOH and 7 N solution of ammonia in MeOH
- customThe desired fractions were collected
- customthe solvents evaporated in vacuo
- customThe product was triturated with DIPE
- customrepurified by RP HPLC on (C18 XBridge 30×100 5 um)
출처 및 근거
- ORD 기록
- ord-41c0541b26e44070951c6afbd4d9db42
- 출처 데이터셋
- uspto-grants-2013_11
- 특허 번호
- US08592422B2
반응 노트
불러오는 중…